CTKBNasdaq United States
Market cap
$545.930 M
$4.20 +0.96%
Close of 7 Aug 2026
Revenue
$201.5M
#2292 by revenue
Earnings
-$66.5M
Loss-making
Shares outstanding
129,983,253
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Cytek Biosciences are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.